000 04276nam a22004095i 4500
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
999 _c99982
_d99982
_x1
001 99982
003 DE-He213
005 20230110040159.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180510s2018 gw | s |||| 0|eng d
020 _a9783319786469
024 7 _a10.1007/978-3-319-78646-9
_2doi
040 _aES-MaUEC
_bspa
_dES-MaUEC
050 4 _aRC280.P7 2018 EB
245 1 0 _aProstate Cancer:
_bClinical Case Scenarios
_cedited by Sam S. Chang, Michael S. Cookson.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XIII, 202 páginas 15 ilustraciones, 10 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aProstate Cancer Screening in African-American Men -- Evaluation and Treatment for Older Men with Elevated PSA -- Utilizing Biomarkers in Patients with Prior Negative Prostate Biopsy -- Active Surveillance in African-Americans -- Focal Therapy versus Surveillance in Intermediate Risk Cancer -- Prostate Cancer Treatment Options for Men with Significant Urinary Symptoms and Enlarged Prostates -- Adjuvant Radiation Therapy for High Risk Post Prostatectomy Patients -- Biochemical Recurrence after Radiation Therapy -- Options After Chemotherapy for Patients with Metastatic, Castration-Resistant Prostate Cancer -- Evaluation and Treatment for High-Risk Prostate Cancer -- High Intensity Focused Ultrasound (HIFU) Options for High-Risk Prostate Cancer -- Radical Prostatectomy in the Metastatic Setting -- Resection of Metastatic Cancer in Castration-Resistant Patients.
520 3 _aThis book provides a single, comprehensive reference source that incorporates all the latest information regarding prostate cancer. It serves as an easy reference source for researchers, clinicians, individuals in training, allied health professionals and medical students regarding prostate cancer by focusing on the controversial points of debate. New data regarding PSA screening, prostate cancer biomarkers, diagnostic evaluation techniques, surveillance protocols, and treatment interventions for localized and more advanced disease are discussed, and gaps in current knowledge and areas for future research are highlighted. Ongoing important clinical trials are also discussed. This text is organized around defined clinical scenarios which are encountered routinely by physicians who care for patients with prostate cancer. The case based format permits presentation of information of concise practical significance. The chapters run the gamut from screening controversies, utility of biomarkers, surveillance strategies, and innovative treatment. The text incorporates key educational concepts in the framework of patient situations with evidence-based discussions of screening, diagnosis, evaluation, and therapeutic management. It also features a comment section from leaders in the field that will be more "opinion-based" allowing the reader to get access to experienced physicians' thought processes and practice patterns. Prostate Cancer: Clinical Case Scenarios will quickly become the ready reference source for professionals and students in various fields with an interest in the management of a complex and multifaceted disease such as prostate cancer.
988 _aSpringer_Medicine_2018
650 7 _aPróstata
_xCáncer
_2embne
_9182337
650 7 _aOncología
_2embne
_9139207
700 1 _aChang, Sam S.
_eeditor literario
_0http://id.loc.gov/authorities/names/no2010177618
_0http://viaf.org/viaf/302960728
_994678
700 1 _aCookson, Michael S
_eeditor literario
776 0 8 _iEdición impresa:
_z9783319786452
776 0 8 _iEdición impresa:
_z9783319786476
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-78646-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2019
_dz
_ef
_feng
_ggw
_h0